# US 2023/0067402 A1 · Isotopically labeled tryptamines and analogs thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0067402 A1
- Document ID: US20230067402A1
- Status: Published application
- Kind: A1
- Application number: 17/887,109
- Filed: 2022-08-12
- Published: 2023-03-02
- Earliest claimed: 2021-08-17
- Assignees: Biomind Labs Inc
- Applicants: Biomind Labs Inc
- Inventors: Lucía Fernanda Minini Rivas; Fernando Amaury Ferreira Chiesa; Dráulio Barros de Araújo; Paola Alexandra Díaz Dellavalle
- Web page: https://patentgrep.com/patent/US20230067402A1

## CPC

- C07D 209/16: Tryptamines
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

The present invention discloses compounds of formula (I) wherein R1 is H, OH, PO4H2, OCH3, or SCH3; wherein R2 is H or and wherein R3 and R4 are H or CH3; and the compound of formula (I) has one or more of a 15N atom and/or a 13C atom. Also disclosed are methods of making the compounds of formula (I), as well as pharmaceutical compositions containing a compound of formula (I) and DMT or 5-MeO-DMT.

## Claims

### Claim 1

A compound of formula (I)
wherein R1 is selected from the group consisting of H, OH, PO4H2, OCH3, and SCH3;
wherein R2 is selected from the group consisting of H and
and
wherein R3 and R4 are independently selected from the group consisting of H and CH3;
or a salt thereof;
wherein the compound of formula (I) comprises one or more of a 15N atom and/or a 13C atom.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the compound is a compound of formula (Ia)
or a salt thereof;
wherein the compound of formula (Ia) comprises one or more of a 15N atom at position 1; a 13C atom at position 2; and a 13C atom at position 3.

### Claim 3 (depends on 1)

The compound of claim 1 wherein the compound is a compound of formula (Ib)
or a salt thereof;
wherein the compound of formula (Ib) comprises one or more of a 15N atom at position 1; a 15N atom attached to position 1′; a 13C atom at position 1′; a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3.

### Claim 4 (depends on 3)

The compound of claim 3, wherein R1 is H, and R3, and R4 are each CH3.

### Claim 5 (depends on 3)

The compound of claim 3, wherein R1 is 5-MeO, and R3 and R4 are each CH3.

### Claim 6 (depends on 4, 5)

The compound of claim 4 or 5, comprising one or more of a 15N atom at position 1 and a 15N atom attached to position 1′.

### Claim 7 (depends on 4, 5)

The compound of claim 4 or 5, wherein comprising one or more of a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3.

### Claim 8

A composition comprising:
i) N,N-dimethyltryptamine (DMT) or 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT); and
ii) a compound of formula (Ib)
or a salt thereof;
wherein R1 is selected from the group consisting of H, OH, PO4H2, OCH3, and SCH3;
wherein R3 and R4 are independently selected from the group consisting of H and CH3; and
wherein the compound of formula (Ib) comprises one or more of a 15N atom at position 1; a 15N atom attached to position 1′; a 13C atom at position 1′; a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3.

### Claim 9 (depends on 8)

The composition of claim 8, comprising 1% or more, 10% or more, 30% or more, or 50% or more of the compound formula (Ib).

### Claim 10 (depends on 8, 9)

The composition of claim 8 or claim 9, wherein the compound of formula (Ib) is selected from the group consisting of a compound having:
a) R1 is H, and R3, and R4 are each CH3 and one or more of a 15N atom at position 1 and a 15N atom attached to position 1′;
b) R1 is H, and R3, and R4 are each CH3 and one or more of a 13C atom at position 1′; a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3;
c) R1 is 5-MeO, and R3 and R4 are each CH3 and one or more of a 15N atom at position 1 and a 15N atom attached to position 1′; and
d) R1 is 5-MeO, and R3 and R4 are each CH3 and one or more of a 13C atom at position 1′; a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3;

### Claim 11 (depends on 8)

The composition of claim 8, comprising DMT and wherein the compound of formula (Ib) is selected from the group consisting of a compound having:
a) R1 is H, and R3, and R4 are each CH3 and one or more of a 15N atom at position 1 and a 15N atom attached to position 1′; and
b) R1 is H, and R3, and R4 are each CH3 and one or more of a 13C atom at position 1′; a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3;.

### Claim 12 (depends on 8, 9)

The composition of claim 8 or claim 9, comprising 5-MeO-DMT and wherein the compound of formula (Ib) is selected from the group consisting of a compound having
c) R1 is 5-MeO, and R3 and R4 are each CH3 and one or more of a 15N atom at position 1 and a 15N atom attached to position 1′; and
d) R1 is 5-MeO, and R3 and R4 are each CH3 and one or more of a 13C atom at position 1′; a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3.

### Claim 13

A method of preparing a compound of formula (Ic)
or a salt thereof,
the method comprising performing a reductive amination reaction on a compound of formula (II)
wherein R1 is selected from the group consisting of H, OH, PO4H2, OCH3, and SCH3; and
wherein the compound of formula (Ic) comprises one or more of a 15N atom and/or a 13C atom.

### Claim 14 (depends on 13)

The method of claim 13, wherein the reductive amination reaction comprises:
i) dissolving the compound of formula (II) and acetic acid in a solvent to form a first solution;
ii) adding to said first solution sodium cyanoborohydride and formaldehyde to form a reaction mixture; and
iii) isolating the compound of formula (Ic).

### Claim 15 (depends on 14)

The method of claim 14, further comprising:
iv) dissolving the compound of formula (Ic) in a solvent and adding fumaric acid; and
v) isolating the fumarate salt of formula (Ic).

### Claim 16 (depends on 13)

The method of claim 13, wherein the compound of formula (II) is selected from a compound having
a 15N label at position 1 and a 13C-label at position 1′ and/or position 2′;
a 13C-label at position C2 and a 13C-label at position 1′ and/or position 2′;
a 13C-labeled at position C3 and a 13C-label at position 1′ and/or position 2′;
a 13C-label at position C2 and a 15N label at the dimethyl substituted N; and
a 13C-label at position 1′ and/or position 2′.

### Claim 17 (depends on 13)

The method of claim 13, wherein the compound of formula 2 is prepared from a tryptophan of formula (III)

### Claim 18 (depends on 17)

The method of claim 17, wherein the tryptophan comprises one or more of a 15N atom at position 1; a 15N atom attached to position 1′; a 13C atom at position 1′; a 13C atom at position 2′; a 13C atom at position 2; and a 13C atom at position 3.
